🇧🇷 Norpace Cr in Brazil

Norpace Cr (DISOPYRAMIDE) regulatory status in Brazil.

Marketing authorisation

ANVISA

  • Status: likely_approved

Norpace Cr in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Cardiovascular approved in Brazil

Frequently asked questions

Is Norpace Cr approved in Brazil?

Yes. ANVISA has authorised it.

Who is the marketing authorisation holder for Norpace Cr in Brazil?

Pfizer is the originator. The local marketing authorisation holder may differ — check the official source linked above.